title: Merkel cell carcinoma with an unusual immunohistochemical profile.
abstract: The clinical and morphological picture of Merkel cell carcinoma (MCC) may be rather challenging; therefore, the immunohistochemical profile plays a relevant role in confirming the microscopic diagnosis. A panel of antibodies including cytokeratins 20, 7 and epithelial membrane antigen, and neuron-specific enolase is used in confirming the morphological diagnosis of MCC. The majority of MCCs express CK20 and are CK7-negative. Herein, we present a case of primary cutaneous neuroendocrine carcinoma with an atypical immunohistochemical pattern. A 83-years old woman presented with a painless plaque, red to violaceous in colour, located in the leg. The skin tumor was excided, formalin-fixed and paraffinembedded. Tissue sections were immunostained with a panel of antibodies routinely utilized in complex primary skin tumors for evidencing epithelial and neuroendocrine differentiation of tumor cells. The neuroendocrine differentiation of tumor cells was evidenced by their immunoreactivity for synaptophysin, chromograninA and neuron-specific enolase. Tumor cells also showed diffuse cytoplasmic staining for CK7. No immunoreactivity was detected for CK20 and thyroid transcription factor-1. Our data, together with previous rare reports of CK20-/CK7+ MCCs, lay stress on the importance of routinely utilizing a panel of antibodies in the differential diagnosis of complex primary carcinomas of the skin and may have important implications in expanding the differential diagnosis of skin tumors. In particular, caution should be taken in excluding the diagnosis of MCC only on the basis of the absence of reactivity of tumor cells for CK20, favouring the wrong diagnosis of less aggressive skin tumors.
authors.affiliation: Department of Cytomorphology, Division of Pathology, University of Cagliari, Italy. lucpilloni@tiscali.it
authors.forename: L
authors.initials: L
authors.lastname: Pilloni
authors.forename: C
authors.initials: C
authors.lastname: Manieli
authors.forename: G
authors.initials: G
authors.lastname: Senes
authors.forename: D
authors.initials: D
authors.lastname: Ribuffo
authors.forename: G
authors.initials: G
authors.lastname: Faa
mesh_terms: D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000378:metabolism; D015266:Carcinoma, Merkel Cell / Q000737:chemistry* / Q000175:diagnosis / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D053554:Keratin-20 / Q000032:analysis* / Q000378:metabolism; D053552:Keratin-7 / Q000032:analysis* / Q000378:metabolism; D012878:Skin Neoplasms / Q000737:chemistry* / Q000175:diagnosis / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor; D053554:Keratin-20; D053552:Keratin-7
references.citation: J Surg Oncol. 2005 Jan 1;89(1):5
references.pmid: 15611999
references.citation: Dermatologica. 1988;177(1):1-10
references.pmid: 3141225
references.citation: Histopathology. 2002 Mar;40(3):230-6
references.pmid: 11895488
references.citation: J Cutan Pathol. 2007 Dec;34(12):918-23
references.pmid: 18001414
references.citation: Am J Surg Pathol. 1985 Feb;9(2):109-16
references.pmid: 2579592
references.citation: Differentiation. 1985;30(2):165-75
references.pmid: 3007249
references.citation: Am J Dermatopathol. 2000 Feb;22(1):65-9
references.pmid: 10698220
references.citation: Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):310-5
references.pmid: 11127923
references.citation: J Invest Dermatol. 1995 Jun;104(6):910-5
references.pmid: 7769257
references.citation: Am J Dermatopathol. 1982 Dec;4(6):497-500
references.pmid: 7165057
references.citation: Exp Dermatol. 1995 Dec;4(6):365-71
references.pmid: 8608344
references.citation: J Clin Oncol. 2002 Jan 15;20(2):588-98
references.pmid: 11786590
references.citation: Pathologica. 2001 Dec;93(6):640-4
references.pmid: 11785114
references.citation: Am J Dermatopathol. 2006 Apr;28(2):99-104
references.pmid: 16625069
references.citation: J Clin Oncol. 2000 Jun;18(12):2493-9
references.pmid: 10856110
references.citation: Pathol Annu. 1984;19 Pt 2:1-30
references.pmid: 6209606
references.citation: Lab Invest. 1985 Apr;52(4):334-53
references.pmid: 2580118
references.citation: Cancer. 1999 Jun 15;85(12):2589-95
references.pmid: 10375107
references.citation: Am J Dermatopathol. 1980 Summer;2(2):101-19
references.pmid: 7246977